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Abstract
Objectives: Most Americans see dentists at least once a year. Chair-side screening
and referral may improve diagnosis of prediabetes and diabetes. In this study, we
developed a multivariate model to screen for dysglycemia (prediabetes and diabetes
defined as HbA1c ≥5.7 percent) using information readily available to dentists and
assessed the prevalence of dysglycemia in general dental practices.
Methods: We recruited 1,033 adults ≥30 years of age without histories of diabetes
from13 general dental practices.A sample of 181 participants selected on the basis of
random capillary glucose levels and periodontal status underwent definitive diag-
nostic testing with hemoglobin A1c. Logistic models were fit to identify risk factors
for dysglycemia, and sample weights were applied to estimate the prevalence of
dysglycemia in the population ≥30 years of age.
Results: Individuals at high risk for dysglycemia could be identified using a ques-
tionnaire that assessed sex, history of hypertension, history of dyslipidemia, history
of lost teeth, and either self-reported bodymass index ≥35 kg/m2 (severe obesity) or
random capillary glucose ≥110 mg/dl. We estimate that 30 percent of patients ≥30
years of age seen in these general dental practices had dysglycemia.
Conclusions:There is a substantial burden of dysglycemia in patients seen in general
dental practices. Simple chair-side screening for dysglycemia that includes or does
not include fingerstick random capillary glucose testing can be used to rapidly iden-
tify high-risk patients.
Practical implications: Further studies are needed to demonstrate the acceptability,
feasibility, effectiveness, and cost-effectiveness of chair-side screening.
Introduction
Diabetes mellitus affects 25.8 million Americans or 8.3
percent of the population (1). Another 79 million Americans
are estimated to have prediabetes (1), the vast majority of
whom are undiagnosed. The US Preventive Services Task
Force has recommended screening for type 2 diabetes in
asymptomatic adults with sustained blood pressure >135/
80 mmHg (2). The American Diabetes Association has rec-
ommended screening for diabetes every 3 years in persons
≥45 years of age and in those <45 years of age with bodymass
index (BMI) ≥25 kg/m2 and one or more risk factors for
diabetes (3).
Approximately 70 percent of Americans see dentists at least
once a year for check-ups and cleanings (4). The concept of
prevention is fundamental to dentistry, and many dental
healthcare professionals have built relationships with their
patients focused on prevention. The American Dental Asso-
ciation has recognized that its members may wish to take
advantage of this relationship to monitor cardiovascular risk
factors (5). There may also be an opportunity to screen for
prediabetes and diabetes during routine dental checkups.
Screening for a disease is appropriate if the disease is
serious; its natural history is understood; it is detectable in its
preclinical stage; the screening test is inexpensive, safe,
acceptable, and valid; early treatment of the disease is more
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effective than late treatment; and screening programs
improve outcomes (6). Type 2 diabetes meets many of these
criteria (7). Screening for diabetes also provides an opportu-
nity to identify people with prediabetes who are at increased
risk for both type 2 diabetes and cardiovascular disease.
Randomized controlled clinical trials have conclusively dem-
onstrated that lifestyle and medication interventions are
effective in delaying or preventing the development of type 2
diabetes in high-risk individuals with prediabetes (8-12).The
failure to translate proven-effective interventions for diabetes
prevention into widespread clinical practice is due in large
part to the difficulty in identifying high-risk individuals. To
help address this problem, investigators have developed and
validated multivariate risk factor models (13-18) and imple-
mented them in a variety of settings including primary care.
In an analysis of data from the Third National Health and
Nutrition Examination Survey (NHANES), Eklund et al.
described prediabetes and diabetes among patients who
reported that they had at least one dental visit during the past
year (Eklund, unpublished observations). At least 10 percent
of patients ≥50 years of age had diabetes and approximately
40 percent had impaired fasting glucose. Perhaps even more
startling and troubling was the fact that one-third to one-half
of those with diabetes andmore than 90 percent of those with
impaired fasting glucose reported that they had never been
told by a doctor that they had diabetes or prediabetes. As a
result, they remained undiagnosed and untreated. This may
ultimately increase the risk of diabetes and its complications
and comorbidities, negatively impact oral health, and pre-
clude appropriate dental care.
The purpose of this studywas to develop and validate a tool
to screen for prediabetes and previously undiagnosed diabe-
tes in dental practices using information readily available to
dental practitioners and to assess the prevalence of prediabe-
tes and previously undiagnosed diabetes in general dental
practices. Because we wanted to develop a tool specifically for
dental practitioners, we assessed essentially all of the risk
factors previously associated with dysglycemia as well as
symptoms and signs of periodontal disease not previously
assessed as risk factors for dysglycemia and used multivariate
analysis to develop a new screening tool.
Methods
FollowingUniversity of Michigan Institutional ReviewBoard
review and approval, we hired and trained research assistants
and assigned them to general dental practices where they
recruited all adults ≥30 years of age with no history of diabe-
tes who were being seen for routine checkups and cleanings.
Recruitment occurred between November 2009 and July
2011. Following written informed consent, patients com-
pleted questionnaires that assessed essentially all of the estab-
lished risk factors for dysglycemia including age, sex, race/
ethnicity, education, income, self-reported height and
weight, self-reported physical activity, history of hyperten-
sion and hypertension treatment, history of dyslipidemia and
lipid treatment, history of cigarette smoking, history of car-
diovascular disease, history of gestational diabetes, family
history of diabetes,medical insurance coverage, and access to
medical care. The questionnaire also assessed symptoms and
signs of periodontal disease including teeth that hurt, painful
gums, teeth that became loose by themselves without injury,
and teeth that were lost from the upper or lower jaw other
than wisdom teeth or teeth extracted to get braces. For pur-
poses of this analysis, answers to the question about lost teeth
were dichotomized as none versus one or more teeth. There-
after, the research assistant performed a random capillary
glucose measurement from each participant’s finger with a
portable blood glucose testing system (FreeStyle Lite blood
glucose meters and test strips, Abbott Diabetes Care Inc.,
Alameda, CA, USA).We have previously assessed the perfor-
mance of random capillary glucose as a screening test and
found a cutpoint of ≥110 mg/dl to be very sensitive in identi-
fying people with previously undiagnosed diabetes regardless
of age and time since last food or drink (19). The hygienist or
dentist then performed a brief periodontal evaluation based
on their usual office practice and indicated the absence or
presence of periodontal disease and its severity. Periodontal
status was initially classified into one of five categories
(Appendix 1). For the purpose of this analysis, periodontal
status was dichotomized as none or gingivitis only versus
early/slight,moderate, or advanced/severe periodontitis.
Because we wished to rigorously evaluate the sensitivity
and specificity of the newly developed screening tool, we per-
formed definitive diagnostic tests on a systematic sample of
the entire study population.All respondents at higher risk for
previously undiagnosed diabetes (random capillary glucose
≥110 mg/dl) and a 50 percent random sample of those at
lower risk for undiagnosed diabetes (random capillary
glucose <110 mg/dl) and all patients with any degree of
hygienist- or dentist-reported periodontitis were invited to
the Michigan Clinical Research Unit for a hemoglobin A1c
(HbA1c) measurement. HbA1c was measured using a Tosoh
G7 HPLC Analyzer (Tosoh Biosciences Inc, South San Fran-
cisco, CA,USA).
HbA1c provides an integratedmeasure of average glycemia
over the past 3 months (20) and has been endorsed by the
International Expert Committee and the American Diabetes
Association for the diagnosis of prediabetes and diabetes
(21). The American Diabetes Association has defined normal
asHbA1c<5.7 percent, prediabetes asHbA1c 5.7-6.4 percent,
and diabetes as HbA1c ≥6.5 percent (3). We defined
dysglycemia as prediabetes or diabetes (HbA1c ≥5.7 percent).
We compared the normal and dysglycemic groups using
one-way analysis of variance when the measure was continu-
ous or a chi-square test when the measure was discrete.
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Logistic regression models were then developed to identify
risk factors for dysglycemia using a backwards elimination
process. We chose to use this approach because all of the
factors that we assessed were potential risk factors for
dysglycemia. Initially, all variables were included in the
model. Then, at each step, the variable that was least signifi-
cant was eliminated until all the terms were significant.Using
the final set of variables, we examined whether interactions
with sexwere significant.To compare the fit of themodels,we
reported the percent of the likelihood chi-square that was
explained by adding variables to the null model.
To estimate the prevalence of dysglycemia in the entire
screenedpopulation,we calculated the number of individuals
in each 10 year age and sex group andmultiplied the number
by the prevalence of dysglycemia in the participants in that
age and sex group who underwent definitive diagnostic
testing (HbA1c). All analyses were performed using SAS 9.2
(SAS Institute, Cary, NC,USA).
Results
Werecruited 1,033 adults≥30 years of agewithout histories of
diabetes from 13 general dental practices in southeastern
Michigan. An additional 106 adults were approached in the
dental practices but declined to participate.The reasons given
for nonparticipation included lack of time, ineligibility due to
diabetes, and unwillingness to provide a capillary blood
sample. All participants provided written informed consent
and completed questionnaires, had random capillary glucose
tests performed by trained research staff using test strips and
portable glucose meters approved for self-monitoring of
blood glucose, and had brief oral examinations performed by
the hygienist or dentist in the office.Themean age (±standard
deviation) of participants was 52.8 ± 12.7 years, 43 percent
were male, and 81 percent were white. The numbers of par-
ticipants recruited from each practice ranged from 13 to 242
with a median of 47.
A total of 354 participants with either random capillary
glucose ≥110 mg/dl and/or periodontitis were invited to the
Michigan Clinical ResearchUnit (MCRU) for definitive diag-
nostic testing and 100 (28 percent) participated. Similarly,
327 participants with random capillary glucose <110 mg/dl
and no periodontitis were invited to the MCRU for testing
and 81 (25 percent) participated. Participants who were
invited for definitive diagnostic testing and attendedwere sig-
nificantly older than those who were invited and did not
attend. Participants with either elevated random capillary
glucose and/or periodontitis who were invited and attended
were 57.4 ± 11.7 years of age comparedwith 54.7 ± 13.9 years
of age for those who were invited and did not attend
(p = 0.0015). Participants with normal random capillary
glucose and no periodontitis who were invited and attended
were 54.1 ± 12.0 years of age comparedwith 50.5 ± 11.9 years
of age for those who were invited and did not attend
(P = 0.0178). Participants with either elevated random capil-
lary glucose and/or periodontitis who were invited and
attended were significantly more likely to have a history of
dyslipidemia than those who were invited and did not attend
(P = 0.0020) and were significantly more likely to have a
history of lost teeth than those who were invited and did not
attend (P = 0.0174). There were no differences between par-
ticipants who were invited and attended and those who were
invited and did not attend with respect to sex, race, BMI,
random capillary glucose, history of hypertension, or history
of cardiovascular disease.Of the 181 participants tested, three
were diagnosed with diabetes based on HbA1c ≥6.5 percent,
57 were diagnosed with prediabetes based on HbA1c 5.7-6.4
percent, and 121 were diagnosed with normal glycemia
(HbA1c <5.7 percent).
Table 1 presents the sociodemographic characteristics
and the prevalence of risk factors by HbA1c category.
Dysglycemiawas associatedwith older age,higher BMI as cal-
culated from self-reported height and weight, and history of
hypertension, dyslipidemia, and myocardial infarction or
stroke. Dysglycemia was associated with both higher random
capillary glucose levels and random capillary glucose
>110 mg/dl. History of loss of one or more teeth was associ-
ated with dysglycemia but clinical evidence of periodontitis
was not. The vast majority of participants reported having
insurance, having a primary care physician (PCP), and seeing
their PCP at least once per year. Dysglycemia was not signifi-
cantly associated with sex, race, income, education, physical
activity, cigarette smoking, family history of diabetes, and
report of painful teeth or loose teeth.
All of the variables in Table 1 were included in a logistic
regressionmodel in which age and BMI were incorporated as
continuous variables. After backwards elimination, the final
model included sex, history of hypertension, history of
dyslipidemia, history of loss of one or more teeth, and
randomcapillary glucose category (<110 versus≥110 mg/dl).
There was a significant interaction between history of
hypertension and sex (Table 2). The variables in the model
explained 24 percent of the likelihood chi-square. When the
same model was fit using random capillary glucose as a con-
tinuous variable, the model explained less of the likelihood
chi-square. When the model was fit without incorporating
random capillary glucose as a categorical or continuous vari-
able, it included sex, history of hypertension, history of
dyslipidemia, history of loss of one or more teeth, and BMI
category (<35 versus ≥35 kg/m2 corresponding to severe
obesity). This model explained 20 percent of the likelihood
chi-square (Table 3).Appendix 2 includes the questions used
to ascertain the variables that entered the final models.
We then identified rules to operationalize the models for
clinical practice and chose cutpoints such that the specificity
of themodels would be approximately 80 percent (in order to
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reduce the number of false positive screening tests).Using the
risk factors in themodel inTable 2 that included randomcap-
illary glucose category, the risk of dysglycemia was high if the
subject was male (with or without hypertension) or female
with hypertension and had two of the following three risk
factors: a history of dyslipidemia, a history of loss of one or
more teeth, and capillary glucose ≥110 mg/dl. The risk of
dysglycemia was also high if the subject was female without
hypertension, and had a history of dyslipidemia, a history of
loss of one or more teeth, and random capillary glucose
≥110 mg/dl.
Using the risk factors in the model in Table 3 that did not
include random capillary glucose category, a male (with or
without hypertension) or a female with hypertension was at
high risk for dysglycemia if he or she had two of the following
three risk factors: a history of dyslipidemia, a history of loss of
one or more teeth, and BMI ≥ 35 kg/m2 (corresponding to
severe obesity). A female without hypertension was at high
Table 1 Sociodemographic Characteristics and Prevalence of Risk Factors by HbA1c Category*
Dysglycemia† Normal‡
P-valuen = 60 n = 121
Age (years) 59.4 ± 9.4 54.3 ± 12.7 0.0027
Sex (male) 34 (56.7) 56 (46.3) 0.21
Race (nonwhite) 16 (26.7) 18 (15.0) 0.070
Income <$50,000 16 (31.4) 20 (18.7) 0.10
Education <college graduate 27 (45.0) 41 (34.5) 0.19
BMI (kg/m2) 30.5 ± 7.4 28.2 ± 5.6 0.042
Inactive 23 (38.3) 48 (40.3) 0.87
Smoke cigarettes (yes) 7 (11.7) 8 (6.7) 0.27
Family history of diabetes (yes) 28 (47.5) 45 (37.8) 0.26
History of hypertension (yes) 34 (56.7) 32 (26.9) 0.0001
History of dyslipidemia (yes) 47 (78.3) 50 (42.0) <0.0001
History of MI or stroke (yes) 11 (18.6) 9 (7.6) 0.04
Random capillary glucose level (mg/dl ± SD) 117 ± 20 104 ± 22 0.0002
Random capillary glucose ≥110 mg/dl 38 (63.3) 34 (28.1) <0.0001
Painful teeth (yes) 8 (13.6) 10 (8.3) 0.30
Loose teeth (yes) 3 (5.0) 6 (5.0) 1.00
One or more lost teeth (yes) 37 (61.7) 48 (40.3) 0.01
Periodontitis (yes) 16 (26.7) 23 (19.0) 0.25
Have insurance (yes) 60 (100.0) 115 (95.8) 0.17
Have PCP (yes) 57 (96.6) 112 (94.1) 0.72
See PCP at least once per year (yes) 43 (87.8) 88 (91.7) 0.55
* Mean ± standard deviation or n (%).
† Dysglycemia defined as HbA1c ≥5.7%.
‡ Normal defined as HbA1c <5.7%.
Table 2 Factors Independently Associated with Prediabetes or Previously Undiagnosed Diabetes When Random Capillary Glucose Is Included
Parameter Coefficient ± standard error Odds ratio (95% CI) P-value
Intercept −0.70 ± 0.20 0.0006
Male with history of hypertension 0.15 ± 0.32 1.2 (0.44-3.11) 0.64
Male without history of hypertension −0.00 ± 0.31 – 0.99
Female with history of hypertension 0.77 ± 0.37 5.4 (1.7-17.2) 0.035
Female without history of hypertension (reference group) −0.92 ± 0.34 – 0.007
History of dyslipidemia 0.67 ± 0.21 3.8 (1.7-8.5) 0.0012
History of lost teeth 0.50 ± 0.19 2.7 (1.3-5.8) 0.0098
Random glucose ≥110 mg/dl 0.66 ± 0.19 3.8 (1.8-7.9) 0.0005
We used a cutpoint of −0.087 as calculated from the logistic regressionmodel (corresponding to a probability of 0.45) to achieve a specificity of 80%and
sensitivity of 60%.
The P-value for the sex by history of hypertension variable is 0.034 with 3 degrees of freedom.
The odds ratio for hypertension compares those with hypertension to those without hypertension within the same sex.
When a parameter is not listed in the table (e.g., random glucose <110 mg/dl), the coefficient is the negative of the coefficient that is given when it is
present.
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risk if she had a history of dyslipidemia, a history of loss of
one or more teeth, and BMI ≥ 35 kg/m2 (corresponding to
severe obesity).Areas under the receiver operator characteris-
tic curves were 0.83 and 0.79 (Fig. 1a and b).When specificity
was 80 percent, the sensitivity to identify dysglycemia was
approximately 60 percent for the first model and 50 percent
for the second.
Applying the observed rates of dysglycemia to the 10-year
age and sex groups, we estimated that 13 (1.3 percent) of the
1,033 screened subjects ≥30 years of age would have previ-
ously undiagnosed diabetes, 297 (28.7 percent) would have
prediabetes, and 723 (70.0 percent) would have normal glyce-
mia (Table 4). Specifically targeting older age groups such as
those ≥45 years of age would improve the yield of screening.
Discussion
In this study, we have demonstrated the predictive value of
simple self-reported risk factors and random capillary
glucose levels in screening for dysglycemia. Risk can be easily
assessed with the one-page instrument provided in Appen-
dix 2 with or without assessment of random capillary
glucose. We have also demonstrated a high prevalence
of dysglycemia among patients receiving screening and
prophylaxis in general dental practices despite the fact that
most report having health insurance,having PCPs, and seeing
their PCP at least once per year.
Borrell et al. analyzed data from NHANES-3 to estimate
the predicted probability of having undiagnosed diabetes
Table 3 Factors Independently Associated with Prediabetes or Previously Undiagnosed Diabetes When Random Capillary Glucose Is Excluded
Parameter Estimate ± standard error Odds ratio (95% CI) P-value
Intercept −0.53 + 0.23 0.0238
Male with history of hypertension 0.31 + 0.31 1.4 (0.5-3.4) 0.32
Male without history of hypertension 0.01 + 0.30 – 0.97
Female with history of hypertension 0.60 + 0.37 4.5 (1.4-14.2) 0.11
Female without history of hypertension (reference group) −0.92 + 0.33 – 0.0056
History of dyslipidemia 0.83 + 0.21 5.3 (2.3-12.1) <.0001
History of lost teeth 0.47 + 0.19 2.5 (1.2-5.3) 0.012
BMI ≥ 35 kg/m2 0.47 + 0.25 2.6 (0.9-7.0) 0.064
We used a cutpoint of -0.087 as calculated from the logistic regressionmodel (corresponding to a probability of 0.45) to achieve a specificity of 80% and
sensitivity of 50%.
The P-value for the sex by history of hypertension variable is 0.039 with 3 degrees of freedom.
The odds ratio for hypertension compares those with hypertension to those without hypertension within the same sex.
When a parameter is not listed in the table (e.g., BMI < 35 kg/m2), its coefficient is the negative of the coefficient that is given when it is present.
Figure 1 Receiver operator characteristic curves. a. Performance of model 2A that includes random capillary glucose category in predicting dysglycemia
[area under the curve (AUC) = 0.83]. b. Performance of model 2B that excludes random capillary glucose category in predicting dysglycemia
(AUC = 0.79).
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(22). They demonstrated that self-reported information
obtained from a standard health history, coupled with find-
ings from a periodontal examination in the dental office that
included probing depth measurements and assessment of
clinical attachment levels resulted in predicted probabilities
of undiagnosed diabetes between 27 percent and 53 percent.
Further analyses from NHANES 2003-2004 demonstrated
that 93 percent of individuals with periodontal disease and 63
percent of those without periodontitis met ADA Guidelines
for diabetes screening (23), highlighting the importance of
periodontal disease and its sequelae as risk factors for
dysglycemia.
Barasch et al. explored the utility of random plasma
glucose levels for screening for prediabetes or previously
undiagnosed diabetes in community dental practices. Of 418
subjects who qualified for testing in 28 dental practices, 18
percent had diabetes or prediabetes (24,25). A follow-up
survey found that blood glucose testing was well-received by
both practitioners and patients (25). Lalla et al. further
explored the feasibility of screening adult patients who pre-
sented for care at a dental clinic and had never been told they
had prediabetes or diabetes. The presence of ≥4missing teeth
or ≥26 percent of teeth with deep pockets correctly identified
73 percent of true cases (26).
Genco et al. recently reported a field trial of screening for
prediabetes and diabetes in dental practices. They screened
1,022 dental patients ≥45 years of age in 11 general and peri-
odontal specialty dental offices and in a dental clinic within a
community health center. Participants had no history of dia-
betes and had not been tested for diabetes in the previous 12
months. Screening was performed with the American Diabe-
tes Association Diabetes Risk Test and a point-of-care capil-
lary hemoglobin A1c test. Nearly 41 percent of participants
had dysglycemia defined by HbA1c ≥5.7 percent. In general,
the ADA Diabetes Risk Test performed poorly in predicting
patients at high risk, and periodontal disease status, as
assessed at the dental sites, added little to theHbA1cmeasure-
ment used for screening (27).
In 2010, Greenberg et al. reported on attitudes toward,
acceptance of, and perceived barriers to chair-side screening
for medical conditions among practicing dentists (28).
Seventy-seven percent thought it was very important or
somewhat important for dentists to perform chair-side
screening for diabetes.Most (85 percent) were very willing to
refer a patient for consultation with a physician. Only 55
percent were very willing to conduct chair-side screening
themselves and only 29 percent were very willing to gather
blood via finger stick. Previous studies from the northeastern
United States (29-31) and New Zealand (32) have indicated
that almost one-third of dentists are unwilling to screen for
diabetes using finger-stick tests and fewer than 3 percent have
ever done so. Strauss et al. have suggested that measurement
of gingival crevicular blood may be a more acceptable
approach to diabetes screening in periodontal patients (33).
Nevertheless, it is clear that although dental practitioners are
receptive to performing preventive activities outside the tra-
ditional scope of dental practice, barriers remain to their
widespread implementation.
The fact that 70 percent of Americans visit their dentists at
least once per year (4) and that 20-50 percent may have undi-
agnosed dysglycemia (Eklund, unpublished data; 24) high-
lights the importance of the dental office as a place to screen
and refer patients for diagnosis and subsequent medical care
of this common and costly systemic disease. Early detection,
prevention, and treatment may not only improve health and
reduce medical costs, but enhance dentists ability to prevent
and treat periodontal disease. Identifying and removing bar-
riers to screening for dysglycemia in dentists’ offices is critical
to widespread implementation. Establishing policies that
support reimbursement for screening may facilitate greater
acceptance by dental practitioners. Cost-effectiveness analy-
ses and assessment of return on investment may also assist in
building a case for policies that facilitate screening in dental
offices.
We have demonstrated that an estimated 30 percent of
nondiabetic adults ≥30 years of age seen in general dental
practices have dysglycemia and that high-risk adults can be
identified using a questionnaire that assesses sex, history
of hypertension, history of dyslipidemia, history of
lost teeth, and random capillary glucose or self-reported
BMI ≥ 35 kg/m2. The results of our studymust be interpreted
with caution because of the low response rate among partici-
pants who were invited for definitive diagnostic testing and
the possibility that thosewho came for testingwere not repre-
sentative of the population of patients seen in general dental
practices. Fortunately, post hoc analyses demonstrated only
Table 4 Estimated Prevalence (Weighted Percentages) of Previously
Undiagnosed Diabetes, Prediabetes, and Normal Glucose Tolerance in
the Population Screened in General Dental Practices by Sex and Age
Diabetes Prediabetes Normal
Women
30-39 years 0.0% 20.0% 80.0%
40-59 years 2.0% 13.9% 84.1%
60+ years 2.6% 43.4% 54.1%
Total 1.8% 23.5% 74.8%
Men
30-39 years 0.0% 15.4% 84.6%
40-59 years 0.0% 43.4% 56.6%
60+ years 1.9% 36.1% 61.9%
Total 0.6% 35.8% 63.6%
Total
30-39 years 0.0% 18.0% 82.0%
40-59 years 1.2% 25.9% 72.9%
60+ years 2.3% 40.0% 57.7%
Total 1.3% 28.7% 70.0%
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minor differences between participants who were invited for
definitive diagnostic testing and attended and those who did
not attend. Although our estimate of the prevalence of
dysglycemia may be high due to the greater likelihood of
follow-up among higher risk patients, we suspect that the
impact is small. In addition, the fact that patients at higher
risk for dysglycemia are more likely to report for definitive
diagnostic testing suggests that if implemented in routine
clinical practice, follow-up may be better among higher risk
patients, thus improving the yield of screening.
This study demonstrates the potential utility of chair-side
screening and referral for definitive diagnostic testing and
treatment. Further studies are needed to demonstrate the
acceptability, feasibility, effectiveness, and cost-effectiveness
of such screening.
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Appendix 1. Guide to general
periodontal assessment (American
Dental Association/American
Academy of Periodontology
Classification)
1. Healthy: absence of gingivitis or periodontitis
2. Gingivitis: “Inflammation of the gingiva characterized
clinically by changes in color, gingival form, position, surface
appearance, and presence of blooding and/or exudate.”
a. No radiographic evidence of bone loss
b. Probing depths may range up to 5 mm (with gingival
swelling)
3. Early/Slight Periodontitis: “Progression of the gingival
inflammation into the deeper periodontal structures and
alveolar bone crest, with slight loss of connective tissue
attachment and alveolar bone.”
a. Radiographic bone loss typically 0-15% of root length
b. Often demonstrates probing depths of 3-6 mm
c. Clinical Attachment Loss 1-2 mm
4. Moderate Periodontitis: “A more advances stage of the
condition, with increased destruction of the periodontal
structures and noticeable loss of bone support, possibly
accompanied by an increase in tooth mobility. There may be
furcation involvement in multi-rooted teeth.”
a. Radiographic bone loss typically 15-30%of root length
b. Often demonstrates probing depths of 4-8 mm
c. Clinical Attachment Loss 3-4 mm
5. Advanced/Severe Periodontitis: “Further progression of
periodontitiswithmajor loss of alveolar bone support usually
accompanied by increased tooth mobility. Furcation involve-
ment in multi-rooted teeth is likely.”
a. Radiographic bone loss >30% of root length
b. Often demonstrates probing depths >6 mm
c. Clinical Attachment Loss ≥5 mm
Appendix 2. Questions used to
ascertain the variables that entered
the final models
1. Today’s date: _ _/ _ _/ 20_ _
Month Day Year
2. Current time: _ _: _ _ AM PM (Circle one)
3. What is your date of birth? _ _/ _ _/ 19_ _
Month Day Year
4. What is your sex?
0□Male
1□ Female
5. Have you ever been told by a physician that you have high
blood pressure or
hypertension?
0□No
1□Yes
8□Not sure
6. Have you ever been told by a physician that you have high
cholesterol or high lipid levels?
0□No
1□Yes
8□Not sure
7. Other than wisdom teeth or teeth pulled to get braces,
have you lost any other
teeth from your upper or lower jaw?
0□No
1□Yes
8. How tall are you without your shoes? _ _feet _ _inches
9. Howmuch do you weigh without clothes? _ _ _Pounds
Calculated BMI: _ _. _kg/m2
Optional:
10. Random capillary glucose level: _ _ _mg/dl
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